178 related articles for article (PubMed ID: 37959314)
1. Clinical Characteristics of Anti-Synthetase Syndrome and Variables Associated with Interstitial Lung Disease and Mortality: A Retrospective Cohort Study.
Sodsri T; Petnak T; Ngamjanyaporn P
J Clin Med; 2023 Oct; 12(21):. PubMed ID: 37959314
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics and prognostic analysis of idiopathic inflammatory myopathy with positive anti-aminoacyl-tRNA synthetase antibodies: A single center experience.
Zhang D; Wang H; Zhou X; Yang J; Liu Y; Wang W; Jiang P; Fan B
Immun Inflamm Dis; 2023 Nov; 11(11):e1085. PubMed ID: 38018600
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the clinical features of antisynthetase syndrome: a retrospective cohort study in China.
Wang R; Zhao Y; Qi F; Wu X; Wang Y; Xu Y; Wu Y; Zhang N; Hou H; Sun W; Li X; Wei W
Clin Rheumatol; 2023 Mar; 42(3):703-709. PubMed ID: 36308573
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors of interstitial lung disease progression at sequential HRCT in anti-synthetase syndrome.
Liu H; Xie S; Liang T; Ma L; Sun H; Dai H; Wang C
Eur Radiol; 2019 Oct; 29(10):5349-5357. PubMed ID: 30919069
[TBL] [Abstract][Full Text] [Related]
5. Clinical features of anti-synthetase syndrome associated interstitial lung disease: a retrospective cohort in China.
Zhan X; Yan W; Wang Y; Li Q; Shi X; Gao Y; Ye Q
BMC Pulm Med; 2021 Feb; 21(1):57. PubMed ID: 33579248
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics of interstitial lung diseases positive to different anti-synthetase antibodies.
Jiang M; Dong X; Zheng Y
Medicine (Baltimore); 2021 May; 100(19):e25816. PubMed ID: 34106621
[TBL] [Abstract][Full Text] [Related]
7. Clinical characterisation of a multicentre nationwide cohort of patients with antisynthetase syndrome.
Martins P; Dourado E; Melo AT; Samões B; Sousa M; Freitas R; Lourenço MH; Fernandes B; Costa E; Parente H; Martins F; Fonseca JE; Cordeiro I; Romão VC; Khmelinskii N; Campanilho-Marques R
ARP Rheumatol; 2022 Nov; 1(ARP Rheumatology, nº3 2022):190-196. PubMed ID: 35891592
[TBL] [Abstract][Full Text] [Related]
8. Clinical features and outcomes of the patients with anti-glycyl tRNA synthetase syndrome.
Zhang Y; Ge Y; Yang H; Chen H; Tian X; Huang Z; Liu S; Lu X; Wang G
Clin Rheumatol; 2020 Aug; 39(8):2417-2424. PubMed ID: 32144624
[TBL] [Abstract][Full Text] [Related]
9. Clinical manifestations of skin, lung and muscle diseases in dermatomyositis positive for anti-aminoacyl tRNA synthetase antibodies.
Fukamatsu H; Hirai Y; Miyake T; Kaji T; Morizane S; Yokoyama E; Hamada T; Oono T; Koyama Y; Norikane S; Iwatsuki K
J Dermatol; 2019 Oct; 46(10):886-897. PubMed ID: 31418479
[TBL] [Abstract][Full Text] [Related]
10. Different Multivariable Risk Factors for Rapid Progressive Interstitial Lung Disease in Anti-MDA5 Positive Dermatomyositis and Anti-Synthetase Syndrome.
Zuo Y; Ye L; Chen F; Shen Y; Lu X; Wang G; Shu X
Front Immunol; 2022; 13():845988. PubMed ID: 35320936
[TBL] [Abstract][Full Text] [Related]
11. [Clinical characteristics of patients with antisynthetase syndrome and interstitial pulmonary disease].
Li W; Li J; Xie WM; Ren YH; Dai HP
Zhonghua Yi Xue Za Zhi; 2020 Jun; 100(24):1861-1865. PubMed ID: 32575928
[No Abstract] [Full Text] [Related]
12. The significance of myositis autoantibodies in idiopathic inflammatory myopathy concomitant with interstitial lung disease.
Huang HL; Lin WC; Lin PY; Weng MY; Sun YT
Neurol Sci; 2021 Jul; 42(7):2855-2864. PubMed ID: 33211209
[TBL] [Abstract][Full Text] [Related]
13. Clinical manifestations and outcome of anti-PL7 positive patients with antisynthetase syndrome.
Marie I; Josse S; Decaux O; Diot E; Landron C; Roblot P; Jouneau S; Hatron PY; Hachulla E; Vittecoq O; Menard JF; Jouen F; Dominique S
Eur J Intern Med; 2013 Jul; 24(5):474-9. PubMed ID: 23375620
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics of patients with anti-EJ antisynthetase syndrome associated interstitial lung disease and literature review.
Liu Y; Liu X; Xie M; Chen Z; He J; Wang Z; Dai J; Cai H
Respir Med; 2020; 165():105920. PubMed ID: 32174452
[TBL] [Abstract][Full Text] [Related]
15. Interstitial Lung Disease in Dermatomyositis Without Myositis-Specific and Myositis-Associated Autoantibodies: Study of a Series of 72 Patients From a Single Cohort.
Chen F; Wang J; Zhang P; Zuo Y; Ye L; Wang G; Shu X
Front Immunol; 2022; 13():879266. PubMed ID: 35603153
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics of anti-isoleucyl-tRNA synthetase antibody associated syndrome and comparison with different patient cohorts.
Ge YP; Zhang YL; Shu XM; Lu X; Wang GC
Clin Exp Rheumatol; 2022 Mar; 40(3):625-630. PubMed ID: 34128807
[TBL] [Abstract][Full Text] [Related]
17. Long-term experience with rituximab in anti-synthetase syndrome-related interstitial lung disease.
Andersson H; Sem M; Lund MB; Aaløkken TM; Günther A; Walle-Hansen R; Garen T; Molberg Ø
Rheumatology (Oxford); 2015 Aug; 54(8):1420-8. PubMed ID: 25740830
[TBL] [Abstract][Full Text] [Related]
18. [Antisynthetase syndromes].
Bauhammer J; Fiehn C
Z Rheumatol; 2019 Sep; 78(7):645-655. PubMed ID: 31346706
[TBL] [Abstract][Full Text] [Related]
19. Antisynthetase Syndrome: A Rare Cause for ILD.
Devi HG; Pasha MM; Padmaja MS; Halappa S
J Clin Diagn Res; 2016 Mar; 10(3):OD08-9. PubMed ID: 27134916
[TBL] [Abstract][Full Text] [Related]
20. Prediction of progressive pulmonary fibrosis in patients with anti-synthetase syndrome-associated interstitial lung disease.
Fu H; Zheng Z; Zhang Z; Yang Y; Cui J; Wang Z; Xue J; Chi S; Cao M; Chen J
Clin Rheumatol; 2023 Jul; 42(7):1917-1929. PubMed ID: 36929316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]